Our in-house laboratory is equipped with high-throughput sequencers and instruments allowing real time production of whole-genome and RNA sequences. With our expertise, minimal genomic DNA (~50ng or less) is sufficient for full sequencing.
We provide actionable insight with fast and accurate big-data analysis. We provide publication-quality annotation and interpretation of whole-genome sequences that are directly applicable for precision medicine and drug development.
We implement whole–genome sequencing in state-of-the-art technologies such as patient-derived organoids, single-cell transcriptomes, and immunology.